eClinical Tech News

Orchestra Biomed Secures $111.2 Million in Funding, Signaling Confidence in Late-Stage Cardiovascular Therapies Orchestra Biomed has successfully closed a...

Agios Pharmaceuticals has secured its first regulatory approval for Pyrukynd (mitapivat) in thalassemia from the Saudi Food and Drug...

Boehringer Ingelheim secures FDA accelerated approval for Hernexeos (zongertinib), an oral tyrosine kinase inhibitor targeting HER2 mutations in advanced...

Annovis Bio has solidified its intellectual property (IP) portfolio for its lead drug candidate, buntanetap, covering both the original...

VTV Therapeutics has initiated its Phase 3 CATT1 trial, evaluating cadisegliatin as an oral adjunctive therapy to insulin for...

Cormedix’s acquisition of Melinta Therapeutics for $300 million, plus potential milestones and royalties, marks a decisive shift in the...

Omass Therapeutics, a UK-based biotech specializing in targeting complex protein ecosystems, has appointed Carol A. Schafer as Non-Executive Director...

Connect, a cornerstone of San Diego’s life science and technology ecosystem, has appointed James Zanewicz as its new CEO....

XOMA Royalty Corporation’s acquisition of Hillevax for $1.95 per share in cash, plus a contingent value right (CVR), marks...

Lift Biosciences Secures €12M Grant to Advance “First-in-Class” Neutrophil Immunotherapy. Lift Biosciences has secured a €12 million grant from...